Biotechnology

With thousands of people dying each day from the pandemic outbreak of 2019 novel coronavirus (COVID-19), 2020 brought challenges previously unseen in the world. As the world reacts and tries to overcome this virus, biotechnology will be the industry to take the lead and forge the path forward. It will not be without difficulty though as the United States (US) must surge and mobilize against an unplanned enemy and must wade through ethical issues previously unrealized. In addition, the triple helix – the interaction between academia, industry, and government – must ensure enough resilience and adaptability to respond to unanticipated circumstances and emerging needs.1 Collaboration within the US triple helix is essential to take advantage of opportunities and mitigate threats.

Biotechnology, defined by the seminar as “Leveraging technology to understand living processes, organisms, and systems to alter and/or enhance health and performance, prevent and cure illnesses and diseases,”2 is often dual-use in nature with related risks and threats to public health and national security, as we are currently witnessing during the pandemic. In 2020 the possibilities and potential advantages of biotechnology have suddenly become extremely important as the world deals with a pandemic claiming hundreds of thousands of lives. The possibilities allowed with new technologies make biotechnology an exciting and fast-changing area of science.

Read the report →